Pertussis (whooping cough) remains an uncontrolled infectious disease despite the institution of universal vaccination in children since the early 1940s. In fact in many developed countries in North America and Europe pertussis has been increasing since 1980. In the United States the number of annually reported cases has increased sixfold since 1980, with 11,647 cases reported in 2003, despite vaccination compliance of more than 80% of young children.1 Pertussis whole-cell vaccine was introduced in Canada in 1943, and the incidence of whooping cough declined by 90% over the subsequent 40 years.2 However, it has increased again in the early 1990s and has remained high since then. The incidence of whooping cough has also increased in recent years in Norway, especially in older children and adults, and in 2004 it was 168 cases per 100,000 of the population.3 The reported incidence rates probably underestimate the true burden of the disease because of incomplete reporting and lack of recognition of the illness.4,5
Young children with pertussis are more easily diagnosed because of presentations with whooping cough, paroxysmal cough episodes followed by an audible inspiratory whoop and sometimes vomiting. Although most children have a persistent but benign illness, serious sequale may occur in infants such as pneumonia, seizures, encephalopathy, and death. Infants can also present with cough and apneic episodes. Immunized infants, older children, adolescents, and adults do not exhibit whooping cough but may have prolonged cough for several weeks.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hewlett, E.L., Edwards, K.M., (2005) Pertussis–not just for kids. N. Engl. J. Med. 352:1215–1222.
Galonis, E., King, A.S. Varughese, P., Halperin, S.A., (2006) Changing epidemiology and emerging risk groups for pertussis. C M A J 174:451–452.
Dudman, S.G., Troseid, M., Jonassen, T.O., Steinbak, K.M., (2006) Whooping cough – an increasing problem in Norway. Tidss Krift fur Den Norske Laegeforening; 126:305–308.
Deeks, S., DeSemes, G., Boulianne, N., Duval, B., Rochette, L., Dery, P., Halperen, S., (1999) Failure of physicians to consider the diagnosis of pertussis in children. Clin. Infect. Dis. 28:840–846.
Crowcroft, N.S., Stein, C., Duclos, P., Birmingham, M., (2003) How best to estimate the global burden of pertussis? Lancet Infect. Dis. 3:413–418.
Loeffelholz, M.J., (2003) Bordetella, in Manual of Clinical Microbiology, 8th Edition; Murray, P.R., Baron, E.J., Jorgensen, J.H., Pfaltler. M.A., Yorken, R.H., A S M Press, Washington DC, pp. 780–788.
Cotter, P.A., Miller, J.F., (2001) Bordetella, in:Principles of bacterial pathogenesis, Groisman, E.A. (Ed) Academic Press, San Diego, CA, pp. 619–674.
Preston, A., (2005) Bordetella pertussis:the intersection of genomies and pathobiology. C M A J 173:55–62.
Heininger, U., Stehr, K., Schmitt-Grohe, S., Lerenz, C., Rost, R., Christenson, P.D., Uberal, M., Cherry, J.D., (1994) Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr. Infect. Dis. J. 13:306–309.
Locht, C., Antoine, R., Raze, d., Mielcarek, N., Hot, D., Lemoine, Y., Mascart, F., (2004) Bordetella pertussis from functional genomics to intranasal vaccination. Int. J. Med. Microbiol. 293:583–588.
Edwards, K.M., (2003) Pertussis an important target for maternal immunization. Vaccine 21:3483–3486.
Stehr, K., Cherry, J.D., Heininger, U., Schmitt-Grohe, S., Uberall, M., Laussucq, S., Eckhardt, T., Meyer, M., Engelhardt, R., Christensen, P., (1998) A comparative efficay trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTA (DtaP) vaccine, the Lederle whole- cell component DT P vaccine or DT vaccine. Pediatrics 101:1–11.
Cherry, J.D., Chang, S.J., Klein, D., Lee, M., Barenkamp, S., Bernstein, D., Edelman, R., Decker, M.D., Greenberg, D.P., Keitel, W., Treanor, J., Ward, J.I., (2004) Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults. Clin. Infect. Dis. 39:1715–1718.
Olin, P., Hallander, H.O., Gustafsson, L., Reizenstein, E., Storsacter, J., (2001) How to make sense of pertussis immunogenicity data. Clin. Infect. Dis. 33 (Suppl.4):S288–S291.
Edelman, K., He, Q., Mäkinen, J., Sahlberg, A., Haanperä, M., Schuermna, L., Wolter, J., Mertsola, J., (2007) Immunity to pertussis 5 Years after booster immunization during adolescence. Clin Infect. Dis. 44:1271–1277.
Crowcroft, N.S., Pebody, R.C., (2006) Recent developments in pertussis. Lancet 367:1926– 1936.
Mills, KH, (2001) Immunity to Bordetella pertussis. Microbes. Infect. 3:655–677.
Wendelboe, AM., van Rie, A, Salmaso, S, Englund, JA (2005) Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. 24:s58–s61.
Cherry, J.D., Grimprel, E., Guiso, N., Heininger, U., Mentsola, J., (2005) Defining pertussis epidemiology:Clinical, microbiologic and serologic perspectives. Pediatr. Infect. Dis. J. 24 (Suppl 5):S25–S34.
Cherry, J.D., (1999) Epidemiological, clinical and laboratory aspects of pertussis in adults. Clin. Infect. Dis. 28(Suppl 2):S112–S117.
Orenstein, W.A., (1999) Pertussis in adults:Epidemiology, signs, symptoms and implications for vaccination. Clin. Infect. Dis. 28 (Suppl 2):S147–S150.
Schellekens, J., von Konig, C.H., Gardner, P., (2005) Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr. Infect. Dis. J. 24 (Suppl. 5):S19–S24.
Lievano, F.A., Reynolds, M.A., Waring, A.L., Ackelsberg, J., Bisgard, K.M., Sanden, G.N., Guris, D., Golaz, A., Bopp, D.J., Limberger, R.J., Smith, P.F., (2002) Issues associated with and recommendation for using PCR to detect outbreaks of pertussis. J. Clin. Microbiol 40:2801–2805.
Halperin, S.A., (2007) The control of pertuiss – 2007 and beyond. N. Engl. J. Med. 356:110–113.
Advisory Committee on Immunization Practices (ACIP) (2006) Preventing tetanus, diphtheria, and pertussis among adolescents:use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines:recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recommen. Rep. 55 (RR-3):1–34.
Ntezayabo, B., De Serres, G., Duval, B., (2003) Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr. Infect. Dis. 22:22–27.
Mastrantonio, P., Spigagha, P., van Oirschot, H., van der Heide, H.G., Heuvelman, K., Stefanelli, P., Mooi, F.R., (1999) Antigenic variants in Bordetalla pertussis strains isolated from vaccinated and unvaccinated children. Microbiology; 145:2069–2075.
Tozzi, A.E., Celentano, L.P., Ciofi degli Atti, M.L., Salmaso, S., (2005) Diagnosis and management of pertussis. C M A J: 172:509–515.
Yaari, E., Yafe-Zimerman, Y., Schwartz, S.B., Slater, P.E., Schvartzman, P., Andoren, N., Branski, D., Kerem, E., (1999) Clinical manifestation of Bordetella pertussis infection in immunized children and young adults. Chest: 115:1254–1258.
Kosters, K., Riffelmann, M., Wirsing vonKonig, C.H., (2001) Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. . J. Med. Microbiol. 50:436–440.
Gilberg, S., Njamkepo, E., Schlumberger, M., Guiso, N, (2002) Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J. Infect. Dis. 186:415–418.
Wirsing von Konig, C.H., Halperin, S., Rifflemann, M., Guiso, N., (2002) Pertussis of adults and infants. Lancet Infect. Dis. 2:744–750.
Pillay, V., Swingler, G., (2003) Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst. Rev. (4):CD 003257.
Widdecombe, J., Shankar, K., (2004) Acute cough in the elderly:aetiology, diagnosis and therapy. Drugs Aging 31:243–258.
Ward, J.I., Cherry I.D., Chang, S.J., Partridge, S., Lee, H., Treanor, J., Greenberg, D.P., Keitel, W., Borenkamp, S., Bernstein, D.I., Edelman, R., Edwards, K., APERT Study Group, (2005) Efficacy of an acellular pertussis vaccine among adolescents and adults. N. Engl. J. Med. 353:1615–1617.
Purdy, K.W., Hoy, J.W., Botterman, M.F., Ward, I.F., (2004) Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults. A cost - benefit analysis. . Clin. Infect. Dis. 39:20–28.
Ward, A., Caro, J., Bassinet, L., Housset, B., O'Brien, J.A., Guiso, N., (2005) Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France. Infect. Control. Hosp. Epidemiol. 26:288–292.
Tablan, O.C., Andersen, J, Besser-May, T., Bridges, C., Hayjeh, R., CDC:Healthcare Infection Control Practices Advisory Committee, (2004) Guidelines for preventing healthcare associated pneumonia, 2003:recommendations of CDC and the HealthCare Infection Control Practices Advisory Committee. M M W R: 53(RR-3): 1–36.
Dodhin, H., Crowcroft, N.S., Bramley, J.C., Miller, E., (2002) U.K. Guidelines for use of erythomycin chemoproplylaxis in persons exposed to pertussis. J. Public Helath Med. 24:200–206.
Hodder, S.L., Cherry, J.D., Montimer, E.A. Jr., Ford, A.B., Gombein, J., Papp, K., (2002) Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin. Infect. Dis. 31:7–14.
Preston, A., Parkhill, J., Maskell, D.J., (2004) The Bordettellae:lessons from genomics. Nat. Rev. Microbiol. 2:379–390.
Forsyth, K.D., Campins-Marti, Caro, J., Cherry, J.D., Greenberg, D., Guiso, N., Heininger, U., Schellekens, J., Tan, T., Wirzing von Konig, C.H., Plotkin S., for the Global Pertussis Initiative, (2004) New pertussis vaccination strategies beyond infancy:Recommendation by the Global Pertussis Initiative. Clin. Infect. Dis. 39:1802–1809.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
(2009). Re-Emergence of Childhood Respiratory Infections in Adults (RSV&Pertussis). In: Fong, I.W. (eds) Emerging Issues and Controversies in Infectious Disease. Emerging Infectious Diseases of the 21st Century. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84841-9_6
Download citation
DOI: https://doi.org/10.1007/978-0-387-84841-9_6
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-84840-2
Online ISBN: 978-0-387-84841-9
eBook Packages: MedicineMedicine (R0)